Drawing for TRINOVA

USPTO serial 99872117

TRINOVA

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
MTANOS, CHRISTOPHER GEORGE
Law office
TMO LAW OFFICE 135

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with TRINOVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Piascik Christoff

Susan Piascik Christoff Cooley LLP?1299 Pennsylvania Avenue, NW, Suite 700ATTN: IP Docketing DepartmentWashington, DC 20004-2400

Goods and services

ClassDescriptionStatusFirst use
010Medical and surgical apparatus and instruments, namely, implantable artificial cardiac valves; Medical and surgical implants made of artificial materials for use in cardiovascular procedures; Medical device consisting of a delivery system for artificial cardiac valves; Medical apparatus and instruments for use in cardiovascular procedures; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for treating valvular regurgitation; Cardiac valves for surgical prostheses; Prostheses for cardiovascular systems, namely, for the heart and heart valves; Artificial cardiac valves; Artificial cardiac valves for implantation as part of the cardiovascular system; Subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; Valve implants consisting of artificial materials for implementation as part of the cardiovascular system; Medical devices for use in treating cardiac disease; Replacement tissue valves comprising artificial and natural, non-living materials for the human heartACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Oct 30, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2026DOCKASSIGNED TO EXAMINER—
Oct 18, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance